Skip to main content
ImmuneCited

Zinc के लिए Upper Respiratory Tract Infections

A

Meta-analysis of 7 trials demonstrates zinc lozenges at 75+ mg/day may reduce cold duration by 33% when started within 24 hours of symptom onset. Zinc acetate lozenges at 80-92 mg/day showed 40% duration reduction. Doses below 75 mg/day showed no effect.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dzinc\u0026condition\u003Dupper\u002Drespiratory\u002Dinfections'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

निष्कर्ष

Meta-analysis of 7 trials demonstrates zinc lozenges at 75+ mg/day may reduce cold duration by 33% when started within 24 hours of symptom onset. Zinc acetate lozenges at 80-92 mg/day showed 40% duration reduction. Doses below 75 mg/day showed no effect.

Key Study Findings

Observational Study n=107 Open-label
Additive effect of free-choice olfactory training combined with pharmacotherapy: A retrospective analysis of post-viral olfactory …
Dose: tokishakuyakusan, zinc sulfate, methylcobalamin बनाम: medication alone Outcome: olfactory function improvement via T&T olfactometry प्रभाव: OR=4.96 p=0.009

जनसंख्या: patients with post-viral olfactory dysfunction (non-COVID)

Review
Exploiting the vulnerability of SARS-CoV-2 with a partnership of mucosal immune function and nutrition: a …
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: None

Review
UCI Sports Nutrition Project: The Role of Nutrition in the Prevention and Management of Illnesses …
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: Elite/professional cyclists nutrition review

Meta-Analysis
Effect of Oral Nutritional Supplementation on Health-Related Outcomes and Nutritional Biomarkers in Children and Adolescents …
Dose: Various oral nutritional supplements बनाम: Standard diet or placebo Outcome: Health outcomes and nutritional biomarkers प्रभाव: None None

जनसंख्या: Children/adolescents with undernutrition

Controlled Clinical Trial n=120 5 weeks Single-blind
Single-Center-Single-Blinded Clinical Trial to Evaluate the Efficacy of a Nutraceutical Containing Boswellia Serrata, Bromelain, Zinc, …
Dose: 20 or 30 days treatment बनाम: Standard treatment only (nasal aerosol) Outcome: Otoscopy, impedance, fibroscopy, pure auditory test प्रभाव: None None

जनसंख्या: Children with otitis media

Review
Associations of fine particulate matter and constituents with pediatric emergency room visits for respiratory diseases …
Dose: 31 μg बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: respiratory disease

Key Statistics

15

अध्ययन

1500

प्रतिभागी

Positive

A

ग्रेड

Referenced Papers

Advances in nutrition … 2013 807 उद्धरण
Pakistan journal of … 2013 33 उद्धरण
Acta scientiarum polonorum. … 2012 11 उद्धरण
American family physician 2012
International journal of … 2011 49 उद्धरण
Journal of trace … 2011 11 उद्धरण
Nihon Jibiinkoka Gakkai … 2009 1 उद्धरण
The Cochrane database … 2007 24 उद्धरण
Clinical evidence 2003
Clinical evidence 2003
American family physician 2002
Canadian journal of … 2001 72 उद्धरण
Zinc for the common cold. Systematic Review
The Cochrane database … 2000 294 उद्धरण
European journal of … 1996 54 उद्धरण
Nederlands tijdschrift voor … 1991
Clinica chimica acta; … 1986 15 उद्धरण
Southern medical journal 1978 3 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
8-11 mg/day
coldtreatment:
75-100 mg/day elemental zinc (lozenges, within 24h of onset, up to 2 weeks)
immunesupport:
15-30 mg/day

अधिकतम सीमा: 40 mg/day (long-term)

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
tokishakuyakusan, zinc sulfate, methylcobalamin -- Positive 107
None -- Mixed --
None -- Mixed --
Various oral nutritional supplements -- Positive --
20 or 30 days treatment 5 weeks Positive 120
31 μg -- Neutral --
94.57% -- Mixed --
None -- Mixed 387

सेवन का सर्वोत्तम समय: Lozenges: dissolve slowly in mouth every 2-3h at cold onset; Supplements: with food to minimize nausea

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Nausea and vomiting (especially on an empty stomach)
  • Metallic taste in the mouth
  • Copper depletion with chronic high-dose use (>40 mg/day)
  • Headache and diarrhea

ज्ञात अंतःक्रियाएँ

  • Copper supplements (zinc inhibits copper absorption at doses >40 mg/day)
  • Tetracycline and quinolone antibiotics (mutual absorption reduction)
  • Penicillamine (zinc reduces absorption of this rheumatoid arthritis drug)
  • Iron supplements (mutual absorption interference when taken together)

सहनीय अधिकतम सेवन: 40 mg/day (long-term)

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Zinc help with Upper Respiratory Tract Infections?
Based on 15 studies with 1,500 participants, there is strong evidence from multiple clinical trials that Zinc may support Upper Respiratory Tract Infections management. Our evidence grade is A (Strong Evidence).
How much Zinc should I take for Upper Respiratory Tract Infections?
Studies have used various dosages. A commonly studied range is 8-11 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Zinc?
Reported side effects may include Nausea and vomiting (especially on an empty stomach), Metallic taste in the mouth, Copper depletion with chronic high-dose use (>40 mg/day), Headache and diarrhea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Zinc and Upper Respiratory Tract Infections?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 15 peer-reviewed studies with 1,500 total participants. The overall direction of effect is positive.

Related Evidence

इसके लिए अन्य सामग्री Upper Respiratory Tract Infections

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।